Position history for BlackRock Finance, Inc.'s holdings in SAREPTA THERAPEUTICS
BlackRock Finance, Inc. holds 10.3M shares of SRPT (SAREPTA THERAPEUTICS), worth $1.6B as of 2024-Q2. The position was increased (+73.2% shares). SRPT represents 0.0% of BlackRock Finance, Inc.'s portfolio.
Current Value
$1.6B
Current Shares
10.3M
Total Value Change
$0
Total Shares Change
0
Other major holders of SRPT: BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC, Capital International Investors
Upgrade to Pro to see multi-quarter position history and trends. View plans
Increased |
| 10.3M |
+73.2% |
| $1.6B |
| 0.0% |
| $158.00 |
48 |